Hubei Jumpcan Pharmaceutical Co., LtdSSE: 600566

Report for Q3 2025

Oct 28, 2025 · Issued by Hubei Jumpcan Pharmaceutical Co., Ltd via Shanghai Stock Exchange

Filed with SSE · Oct 28, 2025

On 6ix: 6ix.com/news/report-for-q3-2025-90

Report for Q3 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Hubei Jumpcan Pharmaceutical Co., Ltd on 6ix

Earlier from Hubei Jumpcan Pharmaceutical

Announcement on Implementation of Independent Exercise in the 1st Exercise Period of Initially Granted Stock Options in 2022 Restricted Stock and Stock Option Incentive PlanOct 10, 2025
Announcement on Lifting Trading Restrictions and Listing of the 1st Trade Restriction Release Period of Initially Granted Restricted Stock under the 2022 Restricted Stock and Stock Option Incentive PlanSep 25, 2025
Announcement on Convening the 2025 Semi-annual Performance BriefingSep 24, 2025
Announcement on Resignation of Non-independent Director and Election of Employee Representative DirectorSep 20, 2025
Announcement on Obtaining Drug Registration Certificate by SubsidiarySep 17, 2025

Later from Hubei Jumpcan Pharmaceutical

Announcement on Progress in Wholly-owned Subsidiaries Opening Special Settlement Account for Cash Management of Raised Funds and Using Idle Raised Funds for Cash ManagementNov 12, 2025
Announcement on Implementation of Repurchase and Cancellation of Partial Restricted Stocks under 2022 Restricted Stock and Stock Option Incentive PlanNov 22, 2025
Announcement on Resolutions of the 19th Meeting of the 10th Board of DirectorsNov 25, 2025
Announcement on Shareholding of Top 10 Shareholders and Top 10 Holders of Shares Without Sales Limit Concerning Shares RepurchaseDec 2, 2025
Announcement on Self-exercise Results and Changes in Share Capital of 2022 Restricted Stock and Stock Option Incentive Plan in Q4 2025Jan 6

All Hubei Jumpcan Pharmaceutical news releases

Follow Hubei Jumpcan Pharmaceutical into a list and get an email when it puts out news.

Follow Hubei Jumpcan Pharmaceutical